Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometry
- 121 Downloads
New approaches are needed for the early detection of breast cancer. Proteomic profiling technologies, such as surface-enhanced laser desorption ionization mass spectrometry (SELDI-MS), may be able to identify tumor markers in biological fluids. The objective of this study was to determine whether there are differences in protein expression patterns in nipple aspirate fluid (NAF) from the cancerous and noncancerous breasts of patients with unilateral breast cancer and the breasts of healthy volunteers. Paired NAF samples were obtained from 23 women with stage I or II unilateral invasive breast carcinoma and five healthy female volunteers. Aliquots of the samples were applied to SELDI Protein-chip arrays (WCX2 and IMAC3-Cu++), and protein expression was analyzed using time-of-flight MS. A total of 463 distinct peaks were detected and analyzed. In breast cancer patients, no differences in protein expression were identified between the breast with the intact primary carcinoma and the contralateral noncancerous breast. Seventeen peaks were overexpressed in cancer-bearing breasts compared to breasts of healthy volunteers (p < 0.0005). When spectra from the nontumor-bearing breasts of breast cancer patients were compared with spectra from breasts of healthy volunteers, two peaks that were overexpressed in breast cancer patients and one peak that was underexpressed in breast cancer patients were detected (p < 0.0027). SELDI-MS was able to identify differences in the phenotypic proteomic profile of NAF samples obtained from patients with early-stage breast cancer and healthy women. Proteomic screening techniques such as SELDI-MS analysis of NAF may be useful for breast cancer screening and diagnosis.
Keywordsbreast cancer mass spectrometry nipple aspirate proteomics SELDI
Unable to display preview. Download preview PDF.
- Sauter, ER, Daly, M, Linahan, K, Ehya, H, Engstrom, PF, Bonney, G, Ross, EA, Yu, H, Diamandis, E 1996Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer riskCancer Epidemiol Biomar Prev5967970Google Scholar
- Kuerer, HM, Goldknopf, IL, Fritsche, H, Krishnamurthy, S, Sheta, EA, Hunt, KK 2002Identification of distinct protein expression patterns in bilateral matched pair breast ductal fluid specimens from women with unilateral invasive breast carcinoma. High-throughput biomarker discoveryCancer9522762282PubMedGoogle Scholar
- Dooley, WC, Ljung, BM, Veronesi, U, Cazzaniga, M, Elledge, RM, O’Shaughnessy, JA, Kuerer, HM, Hung, DT, Khan, SA, Phillips, RF, Ganz, PA, Euhus, DM, Esserman, LJ, Haffty, BG, King, BL, Kelley, MC, Anderson, MM, Schmit, PJ, Clark, RR, Kass, FC, Anderson, BO, Troyan, SL, Arias, RD, Quiring, JN, Love, SM, Page, DL, King, EB 2001Ductal lavage for detection of cellular atypia in women at high risk for breast cancerJ Natl Cancer Inst9316241632PubMedCrossRefGoogle Scholar
- Rogers, MA, Clarke, P, Noble, J, Munro, NP, Paul, A, Selby, PJ, Banks, RE 2003Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: identification of key issues affecting potential clinical utilityCancer Res6369716983PubMedGoogle Scholar
- Paweletz, CP, Gillespie, JW, Ornstein, DK, Simone, NL, Brown, MR, Cole, KA, Wang, QH, Huang, J, Hu, N, Yip, TT, Rich, WE, Kohn, EC, Linehan, WM, Weber, T, Taylor, P, Emmert-Buck, MR, Liotta, LA, Petricoin, EF,III 2000Rapid protein display profiling of cancer progression directly from human tissue using a protein biochipDrug Dev Res493442Google Scholar
- Eggeling, F, Junker, K, Fiedle, W, Wollscheid, V, Durst, M, Claussen, U, Ernst, G 2001Mass spectrometry meets chip technology: a new proteomic tool in cancer researchElectrophoresis2228982902Google Scholar
- Cazares, LH, Adam, BL, Ward, MD, Nasim, S, Schellhammer, PF, Semmes, OJ, Wright, GL,Jr. 2002Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometryClin Cancer Res825412552PubMedGoogle Scholar
- Kuerer HM, Coombes KR, Chen JN, Xiao LC, Clarke C, Fritsche H, Krishnamurthy S, Marcy S, Hung MC, Hunt KK: Association between ductal fluid proteomic expression profiles and the presence of lymph node metastases in women with breast cancer. Surgery (in Press), 2004 Google Scholar
- Benjamini, Y, Hochberg, Y 1995Controlling the false discovery rate: a practical and powerful approach to multiple testingJ Roy Stat Soc57289300Google Scholar
- Fung, ET, Enderwick, C 2002ProteinChip clinical proteomics: computational challenges and solutions.Biotechniques Suppl34–384031Google Scholar